A recent study suggests that the NGF metabolic pathway is impaired in patients with Alzheimer’s disease, finding that the molecular machinery for proNGF maturation is reduced while that for mature NGF degradation is enhanced17. The gene discussed is NGF; the disease is early-onset autosomal dominant Alzheimer disease.